1.
Killing kinetics of clinical isolates of group B streptococci isolated in Belgium for penicillin alone or in combination with gentamicin
Distribution of serotypes of clinical group B streptococci isolated in Belgium: a decade review
2.
3.
Evolution of antimicrobial susceptibility patterns of clinical group B streptococci isolated in Belgium
Antimicrobial Susceptibilities of recent clinical isolates of group B streptococci agalactiae from Belgium
Prevention of Perinatal Group B Streptococcal Diseases: Belgian Guidelines
Susceptibility profile to penicillin, erythromycin and clindamycin of clinical isolates of grup B streptococci recently isolated in Belgium and detection of erythromycin resistance...
Early onset neonatal sepsis or meningitis, in Belgium, in the era of prevention for perinatal group B streptococcal diseases
Serotype Distribution of clinical isolates of group B streptococci Isolated in Belgium : isolates from neonatal infection compared to isolates from infection in adult or colonizati...
Prevalence of ermB, ermTR and mefA/B gene classes among erythromycine resistant group B streptococcus isolates collected in Belgium
Phenotypical and genotypical surveillance of macrolide and lincosamide resistance in group B streptococcus in Belgium
